ProPhase Labs Correlations

PRPH Stock

USD 0.74 0.03 3.90%

The current 90-days correlation between ProPhase Labs and Star Equity Holdings is -0.07 (i.e., Good diversification). The correlation of ProPhase Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

ProPhase Labs Correlation With Market

Good diversification

The correlation between ProPhase Labs and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProPhase Labs and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProPhase Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.

Moving together with ProPhase Stock

0.76	ME	23Andme Holding	Pair Corr
0.77	VALN	Valneva SE ADR	Pair Corr
0.89	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.85	LLY	Eli Lilly	Pair Corr
0.8	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.9	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.7	GMAB	Genmab AS	Pair Corr
0.9	INZY	Inozyme Pharma	Pair Corr
0.61	IPSC	Century Therapeutics	Pair Corr
0.73	LEGN	Legend Biotech Corp	Pair Corr
0.65	MTEM	Molecular Templates	Pair Corr
0.76	NKTX	Nkarta Inc	Pair Corr
0.82	PHAT	Phathom Pharmaceuticals	Pair Corr
0.77	ABBV	AbbVie Inc	Pair Corr

Moving against ProPhase Stock

0.83	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.7	GILD	Gilead Sciences	Pair Corr
0.5	EWTX	Edgewise Therapeutics	Pair Corr
0.35	FBRX	Forte Biosciences Trending	Pair Corr
0.83	RVMD	Revolution Medicines	Pair Corr
0.78	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.73	MNPR	Monopar Therapeutics	Pair Corr
0.7	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.66	RNXT	RenovoRx	Pair Corr
0.6	AKRO	Akero Therapeutics	Pair Corr

Related Correlations Analysis

	LMDX	STRR	ENZ	GTH	STIM	INBS	BDSX	PRPO	DRIO	OLK
LMDX		0.42	0.01	0.28	-0.1	-0.05	0.55	0.01	-0.32	-0.54	LMDX
STRR	0.42		0.41	-0.18	-0.08	0.16	0.89	0.61	0.41	-0.86	STRR
ENZ	0.01	0.41		-0.13	0.19	-0.1	0.3	0.38	0.29	-0.2	ENZ
GTH	0.28	-0.18	-0.13		0.18	0.11	-0.06	-0.57	-0.5	0.03	GTH
STIM	-0.1	-0.08	0.19	0.18		-0.24	-0.22	-0.13	0.2	0.36	STIM
INBS	-0.05	0.16	-0.1	0.11	-0.24		0.11	-0.13	0.06	-0.27	INBS
BDSX	0.55	0.89	0.3	-0.06	-0.22	0.11		0.5	0.18	-0.9	BDSX
PRPO	0.01	0.61	0.38	-0.57	-0.13	-0.13	0.5		0.64	-0.4	PRPO
DRIO	-0.32	0.41	0.29	-0.5	0.2	0.06	0.18	0.64		-0.04	DRIO
OLK	-0.54	-0.86	-0.2	0.03	0.36	-0.27	-0.9	-0.4	-0.04		OLK
	LMDX	STRR	ENZ	GTH	STIM	INBS	BDSX	PRPO	DRIO	OLK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BDSX	+ 0.89	STRR
DRIO	+ 0.64	PRPO
PRPO	+ 0.61	STRR
BDSX	+ 0.55	LMDX
PRPO	+ 0.5	BDSX
STRR	+ 0.42	LMDX

High negative correlations

OLK	- 0.9	BDSX
OLK	- 0.86	STRR
PRPO	- 0.57	GTH
OLK	- 0.54	LMDX
DRIO	- 0.5	GTH
OLK	- 0.4	PRPO

Risk-Adjusted Indicators

There is a big difference between ProPhase Stock performing well and ProPhase Labs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProPhase Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LMDX	4.74	(0.82)	0.00	(9.23)	0.00	0.00	11.54	(10.71)	34.05
STRR	2.32	(0.51)	0.00	4.12	0.00	0.00	4.99	(6.09)	16.59
ENZ	1.27	(0.12)	0.00	(0.31)	0.00	0.00	1.98	(1.94)	7.62
GTH	1.87	(0.01)	(0.03)	0.07	2.49	(2.24)	3.45	(4.08)	14.43
STIM	5.14	0.03	0.02	0.13	7.31	(6.87)	8.99	(9.24)	59.07
INBS	5.65	0.61	0.08	4.45	6.11	(6.65)	13.16	(10.59)	40.29
BDSX	2.60	(0.37)	0.00	3.86	0.00	0.00	5.66	(5.61)	29.48
PRPO	2.15	(0.21)	0.00	(1.10)	0.00	0.00	4.20	(4.48)	11.81
DRIO	3.89	(0.49)	0.00	(0.13)	0.00	0.00	8.99	(6.02)	25.17
OLK	0.63	0.19	0.06	(1.03)	0.48	(0.76)	1.58	(1.37)	4.37

ProPhase Labs Corporate Management

Billy White	Consultant	Profile
Lance Bisesar	Corporate Controller	Profile
Robert Morse	Principal Controller	Profile
Sergio Miralles	Executive Diagnostics	Profile
Kamal Obbad	Senior Genomics	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC